# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-20-009608
Filing Date
2020-04-24
Accepted
2020-04-24 06:03:56
Documents
5
Effectiveness Date
2020-04-24

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | nc10007589x3_defa14a.htm | DEFA14A | 17508
2 |  | nc10007589x3_noticecards1.jpg | GRAPHIC | 497964
3 |  | nc10007589x3_noticecards2.jpg | GRAPHIC | 678805
4 |  | nc10007589x3_noticecards3.jpg | GRAPHIC | 329659
5 |  | nc10007589x3_noticecards4.jpg | GRAPHIC | 113201
| Complete submission text file | 0001140361-20-009608.txt |  | 2249976

Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-19125 | Film No.: 20812399
SIC: 2834 Pharmaceutical Preparations